Burning Rock Biotech Limited
BNR
$16.76
-$0.07-0.42%
NASDAQ
| 12/31/2025 | 09/30/2025 | 03/31/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.17M | -2.34M | -1.86M | -1.86M | -11.30M |
| Total Depreciation and Amortization | 3.05M | -- | -- | -- | 7.14M |
| Total Amortization of Deferred Charges | 19.30K | -- | -- | -- | 113.00K |
| Total Other Non-Cash Items | 10.73M | 4.63M | -1.38M | -1.38M | 11.77M |
| Change in Net Operating Assets | -8.38M | -- | -- | -- | -5.08M |
| Cash from Operations | 3.25M | 2.29M | -3.23M | -3.23M | 2.65M |
| Capital Expenditure | -740.40K | -- | -- | -- | -753.30K |
| Sale of Property, Plant, and Equipment | 121.00K | -- | -- | -- | 217.60K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 574.30K | -383.80K | -210.50K | -210.50K | 422.90K |
| Cash from Investing | -45.10K | -383.80K | -210.50K | -210.50K | -112.90K |
| Total Debt Issued | 2.00M | -- | -- | -- | -- |
| Total Debt Repaid | -100.00K | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -72.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.00M | -- | -- | -- | -2.00K |
| Cash from Financing | -14.10K | -- | -- | -- | -10.30K |
| Foreign Exchange rate Adjustments | -1.20M | -236.40K | 41.50K | 41.50K | 797.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.99M | 1.67M | -3.40M | -3.40M | 3.32M |